Clinical trials: Registration and Transparency

European Respiratory Journal

Volumn 47, Issue 5, 2016, Pages 1342-1344

  Sotgiu, Giovanni ^a   Humbert, Marc ^b,c,d   Dinh Xuan, Anh Tuan ^e   Migliori, Giovanni Battista ^f  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICÊTRE HOSPITAL   (France)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL ETHICS; MEDICAL PRACTICE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGISTRATION; REVIEW; SAMPLE SIZE; SCIENTIFIC LITERATURE; CLINICAL TRIAL (TOPIC); REGISTER;

CLINICAL TRIALS AS TOPIC; HUMANS; REGISTRIES;

EID: 84969776990     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00479-2016     Document Type: Review

References (12)

1. Sotgiu G, Pontali E, Migliori GB. Linezolid to treat MDR-/XDR-tuberculosis: Available evidence and future scenarios. Eur Respir J 2015; 45: 25-29.
2. Berry C, Yates TA, Seddon JA, et al. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: A study in China. Eur Respir J 2016; 47: 1591-1592.
3. Tang S, Yao L, Hao X, et al. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: A study in China. Eur Respir J 2015; 45: 161-170.
4. Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J 2009; 34: 387-393.
5. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012; 40: 1430-1442.
6. Sotgiu G, Centis R, D'Ambrosio L, et al. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. Eur Respir J 2013; 42: 288-290.
7. Tiberi S, Payen MC, Sotgiu G, et al. Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug and extensively drug-resistant tuberculosis. Eur Respir J 2016; 47: 1235-1243.
8. Tiberi S, Sotgiu G, D'Ambrosio L, et al. Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of multidrug and extensively drug-resistant tuberculosis. Eur Respir J 2016; in press [DOI:10.1183/13393003.00214-2016].
9. Krleza-Jerić K, Chan AW, Dickersin K, et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement ( part 1). BMJ 2005; 330: 956-958.
10. Zarin DA, Keselman A. Registering a clinical trial in ClinicalTrials.gov. Chest 2007; 131: 909-912.
11. International Committee of Medical Journal Editors. Clinical Trial Registration. www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html Date last accessed: March 4, 2016.
12. Sterk PJ, Rabe KF. What else can you expect at erj.ersjournals.com? Eur Respir J 2007; 29: 1-3.